BV2 Cells

Categories: Mouse cell lines Description: BV2 cells are a type of microglial cell line derived from C57BL/6 murine, a widely used laboratory mouse strain for animal experiments. These microglial cells have been immortalized using the J2 retrovirus, which carries the v-raf and v-myc oncogenes, resulting in a stable cell line with unique characteristics. BV2 cells express nuclear v-myc and cytoplasmic v-RAF oncogenes, along with the env gp70 antigen on their surface, contributing to their role in immune responses and inflammation within the brain. One of the critical advantages of BV2 cells is their ability to retain the morphological and functional characteristics of primary microglia, the resident immune cells of the central nervous system, making them an ideal model for studying neurodegeneration and brain inflammation. The role of microglia in neurodegeneration, toxicology, and immunity, particularly in conditions such as Alzheimer's disease, is an ever-growing field in biomedical research. Traditional studies often rely on primary microglia cultures and continuous cell preparations. Using a microglia-like cell line, such as BV2 cells, offers a promising alternative by providing a continuous and reproducible source of microglia. BV2 cells, due to v-raf/v-myc expression, show enhanced metabolism and growth, ideal for research on microglial activation and inflammation. Their expression of specific oncogenes and antigens mirrors macrophages, making them valuable for studying immune responses and disease mechanisms. A recent re-evaluation of mice BV2 microglia cells examined their suitability as a substitute for primary microglia (PM). The response of BV2 cells to lipopolysaccharide was compared with that of microglia in both in vitro and in vivo settings, however, with the upregulation of genes being slightly less pronounced on average. BV2 cells displayed normal regulation of nitric oxide and functional response to IFN-gamma, critical parameters for their interaction with T cells, neurons, and other glial cells such as astrocytes. BV2 cells were also found to stimulate other glial cells effectively, leading to the production of interleukin-6 (IL-6) in astrocytes. This interaction between astrocytes and microglia is crucial for understanding the complex cell-cell interactions and the inflammatory response in the brain, especially in the context of neurodegenerative diseases like Alzheimer's, where proteins such as NAPoe31 and NAPoe41, as well as pathways like the startle response and apoptosis, play significant roles. BV2 cells offer a robust and reliable tool for researchers in microglial biology. Their expression of v-raf/v-myc oncogene products enables them to retain key characteristics of microglia and macrophages. BV2 cells have proven to be a valid substitute for primary microglia in various experimental settings, facilitating research on neurodegeneration, toxicology, immunity, and cell-cell interactions. Organism: Mouse Tissue: Brain Synonyms: BV-2 Breed: C57BL/6 Age: 1 week Gender: Female Morphology: Morphology microglial Growth Properties: Adherent Citation: BV2 (Cytion catalog number 305156) Biosafety Level: 1 Ncbi_ Taxid: 10090.0 Cellosaurus Accession: CVCL_0182 Culture Medium: RPMI 1640, w: 2.0 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a) Supplements: Supplement the medium with 10% FBS Dissociation Reagent: Accutase Subculturing: Gather the suspension cells in a 15 ml tube and gently wash the adherent cells with PBS lacking calcium and magnesium (use 3-5 ml for T25 flasks and 5-10 ml for T75 flasks). Apply Accutase (1-2 ml for T25 flasks, 2.5 ml for T75 flasks) ensuring full coverage of the cell layer. Allow the cells to incubate at room temperature for 10 minutes. Following incubation, combine and centrifuge both the suspension and adherent cells. After centrifugation, carefully resuspend the cell pellet and transfer the cell suspension into new flasks containing fresh medium. Fluid Renewal: 2 to 3 times per week Freeze Medium: As a cryopreservation medium, use complete growth medium (including FBS) + 10% DMSO for adequate post-thaw viability, or CM-1 (Cytion catalog number 800100), which includes optimized osmoprotectants and metabolic stabilizers to enhance recovery and reduce cryo-induced stress. Thawing And Culturing Cells: Confirm that the vial remains deeply frozen upon delivery, as cells are shipped on dry ice to maintain optimal temperatures during transit. Upon receipt, either store the cryovial immediately at temperatures below -150°C to ensure the preservation of cellular integrity, or proceed to step 3 if immediate culturing is required. For immediate culturing, swiftly thaw the vial by immersing it in a 37°C water bath with clean water and an antimicrobial agent, agitating gently for 40-60 seconds until a small ice clump remains. Perform all subsequent steps under sterile conditions in a flow hood, disinfecting the cryovial with 70% ethanol before opening. Carefully open the disinfected vial and transfer the cell suspension into a 15 ml centrifuge tube containing 8 ml of room-temperature culture medium, mixing gently. Centrifuge the mixture at 300 x g for 3 minutes to separate the cells and carefully discard the supernatant containing residual freezing medium. Gently resuspend the cell pellet in 10 ml of fresh culture medium. For adherent cells, divide the suspension between two T25 culture flasks, for suspension cultures, transfer all the medium into one T25 flask to promote effective cell interaction and growth. Adhere to established subculture protocols for continued growth and maintenance of the cell line, ensuring reliable experimental outcomes. Sterility: Mycoplasma contamination is excluded using both PCR-based assays and luminescence-based mycoplasma detection methods. To ensure there is no bacterial, fungal, or yeast contamination, cell cultures are subjected to daily visual inspections. Safety Precautions: When planning to store a cryovial in liquid nitrogen for future thawing, it is mandatory to adhere to stringent safety measures. Appropriate protective gloves and clothing are essential, and the use of a face mask or safety goggles is required during the transfer of frozen samples to or from the liquid nitrogen tank. This is to mitigate the risk of injury from potential cryovial explosions upon removal, which can result in the projection of sharp fragments. Warranty: We stand by the promise of delivering products with high cell viability and robust culture performance. To achieve the best results, please make sure you follow the storage and culture instructions detailed in the product information sheet closely. Your adherence to these guidelines is key to success. Subject To Material Transfer Agreements: If you intend to use Cytion cell lines solely for internal research at a single research site, please complete and sign our Material Transfer Agreement (MTA) and submit it along with your order.For any commercial applications - including but not limited to fee-for-service work, quality control testing, product release, diagnostic use, or regulatory studies - please complete the Intended Use Form so we can prepare a suitable agreement tailored to your project.Please note: The MTA applies only to certain cell lines. If this notice and the MTA document appear on a product page, the agreement is applicable. For cell lines not covered by the MTA, no reference to the agreement will be shown. The MTA is not valid for customers in the Americas, China, or Taiwan. Please contact our U.S. entity to receive the appropriate agreement. Required Product 1: 820700a Required Product 3: 860015.0 Required Product 4: 830100.0